Oncopeptides AB (publ) (LON:0RN4)
1.492
+0.012 (0.81%)
At close: Feb 21, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 24.09 million as of February 21, 2025. Its market cap has decreased by -49.23% in one year.
Market Cap
24.09M
Enterprise Value
14.21M
Revenue
1.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.49
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 24.09M, a decrease of -83.84%. That is a compound annual growth rate of -20.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 179.71B |
Shell | 164.13B |
HSBC Holdings | 156.44B |
Unilever | 110.18B |
Rio Tinto Group | 85.95B |
RELX PLC | 73.75B |
BP p.l.c. | 70.76B |
British American Tobacco p.l.c. | 66.72B |